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Abstract We studied the e¡ects of ¢broblast growth factor
(FGF-10) on alveolar epithelial cell (AEC) Na,K-ATPase reg-
ulation. Within 30 min FGF-10 increased Na,K-ATPase activity
and K1 protein abundance by 2.5-fold at the AEC plasma mem-
brane. Pretreatment of AEC with the mitogen-activated protein
kinase (MAPK) inhibitor U0126, a Grb2-SOS inhibitor (SH3-
b-p peptide), or a Ras inhibitor (farnesyl transferase inhibitor
(FTI 277)), as well as N17-AEC that express a Ras dominant
negative protein each prevented FGF-10-mediated Na,K-ATP-
ase recruitment to the AEC plasma membrane. Accordingly, we
provide ¢rst evidence that FGF-10 upregulates (short-term) the
Na,K-ATPase activity in AEC via the Grb2-SOS/Ras/MAPK
pathway.
8 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Lung edema clearance is e¡ected by the osmotic gradient
established by active vectorial Naþ transport. Alveolar epithe-
lial cell (AEC) Na,K-ATPase contributes to active sodium
transport. Recent data indicate that upregulation of Na,K-
ATPase is su⁄cient to increase alveolar £uid clearance [1^3].
Various agents such as dopamine, adrenergic agonists, miner-
alocorticoids and epidermal growth factor (EGF) increase £u-
id clearance by upregulating the alveolar epithelial Na,K-
ATPase [4,5]. Na,K-ATPase activity is subjected to both
short-term and long-term hormonal regulation (e.g. aldoste-
rone, thyroid hormone) [4,5]. Short-term regulation of the
Na,K-ATPase function can be achieved by increasing the
number of molecules at the plasma membrane, changes in
the catalytic property of enzymes already present at the plas-
ma membrane, and by changes in enzyme a⁄nity for sodium.
Both keratinocyte growth factor (KGF) and EGF were re-
ported to increase ion transport across AEC monolayers
and lung edema clearance after 24^72 h exposure [6^9]. How-
ever, there is no information about the short-term e¡ects (less
than 60 min) of growth factors on Na,K-ATPase in the lungs.
Fibroblast growth factor-10 (FGF-10), a 19.3 kDa heparin
binding protein structurally similar to KGF, is a potent AEC
mitogen, promotes epithelial cell di¡erentiation, migration,
wound healing, prevents oxidant and cyclic stretch-induced
DNA damage and is required for lung development [10^15].
Mitogen-activated protein kinase (MAPK) is a major signal
transduction system by which cells transduce extracellular sig-
nals into intracellular responses. Several reports suggest an
important role of the MAPK signal transduction pathway in
the regulation of Na,K-ATPase. L-Adrenergic agonists as well
as dopamine stimulate MAPK activation that results in (long-
term, s 12 h) upregulation of Na,K-ATPase [16,17]. MAPK
pathway signaling typically occurs when growth factors, such
as FGF-10, bind to their receptors resulting in downstream
activation of MAPK family proteins that include extracellular
signal-regulated kinases 1 and 2 (ERK-1/2) [14,15,18]. Because
the Grb2-SOS, Ras and MAPK pathway plays a key role in
mediating the protective e¡ects of FGF-10 against cyclic
stretch- and oxidant-induced AEC injury [14,15], we explored
whether FGF-10 augments Na,K-ATPase activity by MAPK-
dependent signal transduction pathways.
2. Materials and methods
2.1. Materials
FGF-10 was purchased from RpD systems (Minneapolis, MN,
USA). U0126 was purchased from Promega (Madison, WI, USA).
EZ-link NHS-SS-biotin and streptavidin beads were purchased from
Pierce (Rockford, IL, USA). A monoclonal antibody speci¢c to the
Na,K-ATPase K1 subunit was obtained from Upstate Biotechnology,
(Lake Placid, NY, USA). All other chemicals were purchased from
Sigma (St. Louis, MO, USA).
2.2. Cell culture
A549 cells were obtained from the American Type Culture Collec-
tion (ATCC, Manassas, VA, USA) and maintained in Dulbecco’s
modi¢ed Eagle’s medium supplemented with L-glutamine (0.3 Wg/
ml), non-essential amino acids, penicillin (100 U/ml), streptomycin
(200 Wg/ml), and 10% fetal bovine serum (Gibco, Grand Island,
NY, USA). For each experiment, we used a seeding density of
3.0U105 cells/ml/well plated in six-well plates (Costar, Cambridge,
MA, USA). The cells were grown to con£uence over 24 h in a hu-
midi¢ed 95% air^5% CO2 incubator at 37‡C.
2.3. Biotinylation of cell surface proteins
Cells were treated with di¡erent agonists/antagonists at 37‡C,
placed on ice, washed twice with ice-cold phosphate-bu¡ered saline
(PBS), and surface proteins were labeled for 1 h using 0.5 mg/ml EZ-
link NHS-SS-biotin. After labeling, the cells were rinsed three times
with PBS containing 50 mM glycine to quench unreacted biotin, and
then lysed in modi¢ed RIPA bu¡er (50 mM Tris^HCl, pH 8, 150 mM
NaCl, 1% NP-40 and 1% sodium deoxycholate, 1 Wg/ml leupeptin, 100
Wg/ml N-tosyl-L-phenylalanine chloromethyl ketone and 1 mM phen-
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ylmethylsulfonyl £uoride). 150^300 Wg proteins were incubated over-
night at 4‡C with end-over-end shaking in the presence of streptavidin
beads. Beads were thoroughly washed [19], resuspended in 30 Wl of
Laemmli’s sample bu¡er solution [20] and analyzed by Western blot
using a monoclonal antibody speci¢c to the Na,K-ATPase K1 subunit.
2.4. Western blot analysis
Proteins were size fractionated by 1% sodium dodecyl sulfate/10%
polyacrylamide gel electrophoresis and transferred to nitrocellulose
membranes (Optitran, Schleicher and Schuell, Keene, NH, USA) us-
ing a semi-dry transfer apparatus (Bio-Rad, Hercules, CA, USA).
Incubation of blots with a monoclonal antibody speci¢c to the
Na,K-ATPase K1 subunit (0.05 Wg/ml) (Upstate Biotechnology) was
performed overnight at 4‡C. Blots were developed with an enhanced
chemiluminescence detection kit (ECLþ, Amersham, Buckingham-
shire, UK) used as recommended by the manufacturer. The bands
were quanti¢ed by densitometric scan (Eagle Eye II, Stratagene, La
Jolla, CA, USA).
2.5. Na,K-ATPase activity
Na,K-ATPase activity was determined as described before [21].
Brie£y, after cells were incubated with the desired conditions, they
were placed on ice and washed, and aliquots (V10 Wg of protein)
were transferred to the Na,K-ATPase assay medium, containing (in
mM) 50 NaCl, 5 KCl, 10 MgCl2, 1 EGTA, 50 Tris^HCl, and
7 Na2ATP and [Q-32P]ATP (speci¢c activity 3000 Ci/mmol) in trace
amounts (3.3 nCi/Wl). Cells were transiently exposed to a thermic
shock to render the membrane permeable to ATP. The samples
were incubated at 37‡C for 15 min and the reaction was terminated
by the addition of 700 Wl of a trichloroacetic acid:charcoal (5:10 w/v)
suspension and rapid cooling to 4‡C. After the charcoal phase con-
taining the unhydrolyzed nucleotide was separated (12 000Ug for
5 min), the liberated 32P was counted in an aliquot. The Na,K-ATP-
ase activity was calculated as the di¡erence between the samples as-
sayed in the same medium but devoid of Naþ and Kþ and in the
presence of 2.5 mM ouabain (ouabain-insensitive ATPase activity).
Fig. 1. a: FGF-10 upregulates (short-term) the AEC Na,K-ATPase.
AEC were treated with FGF-10 (200 ng/ml) for 30 min. Na,K-ATP-
ase K1 subunit protein abundance was assessed by biotinylation of
cell surface proteins by Western blot. Compared to controls, FGF-
10 increased Na,K-ATPase K1 subunit protein abundance. b: AEC
were treated with FGF-10 (200 ng/ml) for 30 min. Na,K-ATPase
activity was assessed by 32P radiolabel assay. Compared to control,
FGF-10 increased Na,K-ATPase activity by V2-fold. Pretreatment
of AEC with U0126 for 1.5 h blocked the increase in activity.
c: AEC were pretreated with a speci¢c MAPK inhibitor (U0126: 10
WM) for 1.5 h followed by treatment with FGF-10 (200 ng/ml) for
30 min. Na,K-ATPase K1 was assessed by biotinylation of cell sur-
face proteins. U0126 blocked the FGF-10 e¡ects. All data are ex-
pressed as meansSS.E.M., n=3. *P6 .05 vs. control.
Fig. 2. FGF-10 regulation of AEC Na,K-ATPase is mediated by
the Grb2-SOS/Ras/MAPK pathways. a: Pretreatment of AEC with
SH3b-p for 2 h or the Ras inhibitor FTI 277 (10 WM) for 15 min
prior to FGF-10 (200 ng/ml) blocked the FGF-10-mediated Na,
K-ATPase upregulation. *p6 0.05 Control vs. FGF-10, 2p6 0.05
FGF-10 vs SH3b-p+FGF-10, FTI+FGF-10. b: In N17-A549 cells
expressing a Ras dominant negative protein treated with FGF-10
(200 ng/ml) did not increase the Na,K-ATPase. Data are presented
as meansSS.E.M., n=3, *P6 0.05
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2.6. Statistical analysis
Data are reported as meanSS.E.M. Statistical analysis was done by
one-way analysis of variance and Tukey tests. Results were considered
signi¢cant when P6 0.05.
3. Results and discussion
Growth factors are known to play a role in recovery from
lung injury and to increase lung edema clearance [22^27].
EGF and KGF increased short-circuit current in AEC mono-
layers, upregulated Na,K-ATPase and increased lung liquid
clearance [6,23^28] after V24 h of exposure. Given the im-
portant role of growth factors regulating Na,K-ATPase in the
lungs in the long term, we designed experiments to determine
the short-term (6 60 min) e¡ects of FGF-10, a potent AEC
mitogen, on the Na,K-ATPase in AEC. We incubated AEC
with FGF-10 (200 ng/ml) for 30 min and observed a 2.5-fold
increase in K1 Na,K-ATPase protein abundance, assessed by
biotinylation of AEC surface proteins (Fig. 1a). Na,K-ATP-
ase translocation to the plasma membrane from intracellular
compartments occurred without changing the Na,K-ATPase
K1 subunit protein abundance in total cell lysates and resulted
in an increase in Na,K-ATPase activity (Fig. 1b). Taken to-
gether, these data demonstrate short-term regulation (recruit-
ment from intracellular pools) of Na,K-ATPase by FGF-10 in
AEC.
The role of MAPK in the long-term (V24 h) regulation of
Na,K-ATPase has been previously reported during dopami-
nergic type 2 receptor and L-agonist-mediated stimulation of
Na,K-ATPase in AEC [16,17]. Given the role of MAPK in
mediating the e¡ects of FGF-10 as well as in regulation of
Na,K-ATPase, we sought to determine the role of the MAPK
pathway in the regulation of Na,K-ATPase by FGF-10. We
treated AEC with a speci¢c MAPK inhibitor (U0126: 10 WM)
for 1.5 h followed by treatment with FGF-10 (200 ng/ml) for
30 min and as shown in Fig. 1b,c, U0126 blocked FGF-10-
induced upregulation of AEC K1 Na,K-ATPase protein abun-
dance at the plasma membrane as well as activity.
To investigate the role of upstream e¡ectors of MAPK
pathways, we incubated AEC with a SH3 binding domain
inhibitor (SH3b-p; 10 WM) for 2 h [29,30] or a Ras inhibitor,
farnesyl transferase inhibitor (FTI 277; 10 WM) for 30 min
prior to treating the cells with FGF-10 (200 ng/ml). As shown
in Fig. 2a, these inhibitors blocked FGF-10-mediated K1
Na,K-ATPase upregulation. Furthermore, we generated
A549 cells expressing a Ras dominant negative protein
(N17) which upon incubation with FGF-10 did not have an
increase in Na,K-ATPase at the AEC plasma membrane (Fig.
2b) [30]. Taken together, these data suggest that FGF-10-in-
duced (short-term) upregulation of AEC Na,K-ATPase occurs
via the Grb2-SOS/Ras/MAPK pathways.
In summary, we provide the ¢rst evidence that FGF-10-
mediated increase in Na,K-ATPase activity and protein abun-
dance at the plasma membrane of AEC function occurs within
30 min via the Grb2-SOS/Ras/MAPK pathways without in-
creasing the whole cell Na,K-ATPase K1 protein expression
(Fig. 3). We speculate that this novel mechanism of Na,K-
ATPase regulation by FGF-10 may be of physiologic signi¢-
cance.
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